[ FDA ENFORCEMENT INTELLIGENCE ]

Learn from the record. Every FDA recall is a quality signal.

Live drug, device & food recall data from the FDA (openFDA enforcement) — food spanning dietary supplements, cosmetics & animal food — mapped to the GxP quality domains SPEQ assesses, so you can see where control breaks down across every regulated industry.

1,000

Total recalls

217

Class I (most serious)

167

Drug

515

Device

318

Food / supplement / cosmetic

Last 12 months · latest report 2026-07-22 · source: openFDA enforcement

RECALLS BY CLASSIFICATION · MONTHLY

RECALL REASONS BY QUALITY DOMAIN

Domain mapping is a SPEQ interpretation of the FDA recall reason, not an official FDA classification.

3,493 matching recalls

Date	Class	Firm	Reason	Quality domain
2026-07-22	Class I	Argon Medical Devices, IncZ-2709-2026	Kits containing Lidocaine HCL Injection USP 1% 10mg/mL 5mL ampules subject to another recall recalled due to not meeting release criteria for sterility.	Environmental Monitoring
2026-07-22	Class I	Abiomed, Inc.Z-2684-2026	A potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These manufacturing issues are not visually detectable by the user, and 14Fr or 23Fr Introducers are provided in every pump set.	Risk Management & CAPA
2026-07-22	Class II	Orthofix U.S. LLCZ-2729-2026	Unilateral external fixation devices may be incorrectly labeled. Minirail M101 was labeled as M103, Minirail M103 was labeled as M101, and Minirail M122 was labeled as M111	Documentation & Change Control
2026-07-22	Class II	Papablic IncZ-2733-2026	Potential for brush heads to break.	—
2026-07-22	Class II	Olympus Corporation of the AmericasZ-2720-2026	Some sterilization parameters included in the IFU may not consistently render the devices adequately sterile and therefore should no longer be used to sterilize the devices.	Environmental Monitoring
2026-07-22	Class I	Oscor Inc.Z-2678-2026	Due to manufacturing issues, there is a potential for the 14Fr and 23Fr introducer sheaths to leak from the sidearm, under the sheath cap, and along the hub score lines in the hub region.	Risk Management & CAPA
2026-07-22	Class II	ICU Medical, Inc.Z-2724-2026	In a specific scenario, the pump will not decrement the Volume to be Infused (VTBI) displayed on the Delivery screen and may deliver up to twice the VTBI at the programmed rate.	—
2026-07-22	Class I	Argon Medical Devices, IncZ-2705-2026	Kits containing Lidocaine HCL Injection USP 1% 10mg/mL 5mL ampules subject to another recall recalled due to not meeting release criteria for sterility.	Environmental Monitoring
2026-07-22	Class I	Abiomed, Inc.Z-2689-2026	A potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These manufacturing issues are not visually detectable by the user, and 14Fr or 23Fr Introducers are provided in every pump set.	Risk Management & CAPA
2026-07-22	Class II	Orthofix U.S. LLCZ-2732-2026	Unilateral external fixation devices may be incorrectly labeled. Minirail M101 was labeled as M103, Minirail M103 was labeled as M101, and Minirail M122 was labeled as M111	Documentation & Change Control
2026-07-22	Class I	Argon Medical Devices, IncZ-2707-2026	Kits containing Lidocaine HCL Injection USP 1% 10mg/mL 5mL ampules subject to another recall recalled due to not meeting release criteria for sterility.	Environmental Monitoring
2026-07-22	Class I	Abiomed, Inc.Z-2688-2026	A potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These manufacturing issues are not visually detectable by the user, and 14Fr or 23Fr Introducers are provided in every pump set.	Risk Management & CAPA
2026-07-22	Class I	Abiomed, Inc.Z-2687-2026	A potential for introducer sheath leakage from under the sheath cap and along the hub score lines, identified in 14Fr and 23Fr Introducers. These manufacturing issues are not visually detectable by the user, and 14Fr or 23Fr Introducers are provided in every pump set.	Risk Management & CAPA
2026-07-22	Class II	Boston Scientific CorporationZ-2725-2026	Devices contain recalled Medline Namic Angiographic Control Syringe with Rotating Adaptor. There is a risk of syringe loosening or disconnecting from the manifold, resulting in loose connection or complete disconnection. May lead to difficulty connecting syringe, inability to aspirate or inject properly, fluid leakage, or separation of the syringe from the system, potentially requiring device exchange and prolonging the procedure.	—
2026-07-15	Class II	Reliance Life Sciences Private LimitedD-0671-2026	Lack of Sterility Assurance	Environmental Monitoring
2026-07-15	Class II	Reliance Life Sciences Private LimitedD-0673-2026	Lack of Sterility Assurance	Environmental Monitoring
2026-07-15	Class II	Gasco Industrial Corp.D-0668-2026	Subpotent drug	Validation & Qualification
2026-07-15	Class II	Reliance Life Sciences Private LimitedD-0672-2026	Lack of Sterility Assurance	Environmental Monitoring
2026-07-15	Class II	Shimoga ChemicalsD-0691-2026	cGMP deviations	Risk Management & CAPA
2026-07-15	Class II	Gasco Industrial Corp.D-0670-2026	Subpotent drug	Validation & Qualification
2026-07-15	Class II	Gasco Industrial Corp.D-0667-2026	Subpotent drug	Validation & Qualification
2026-07-15	Class II	Gasco Industrial Corp.D-0666-2026	Subpotent drug	Validation & Qualification
2026-07-15	Class II	BioMed Laboratories, LLC.D-0663-2026	Failed Impurities/Degradation Specifications; Formaldehyde levels exceeded specification.	Validation & Qualification
2026-07-15	Class II	Gasco Industrial Corp.D-0665-2026	Subpotent drug	Validation & Qualification
2026-07-15	Class II	ONESOURCE SPECIALTY PHARMA LIMITEDD-0662-2026	Failed Impurities/Degradation Specifications	Validation & Qualification

Page 4 of 140

← Prev Next →

Data: U.S. FDA openFDA enforcement API. Quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Recall details are as reported by the FDA.